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We aim to validate a European-Portuguese version of the Hypertension Knowledge Test (HKT) 
questionnaire and examine its factorial structure with a confirmatory factor analysis (CFA). A process 
of translation and back-translation was performed. A cross-sectional study was developed in which all 
adult patients taking at least one antihypertensive drug were invited to participate. Data on personal and 
family history were collected, and the HKT, Strelec, and the Batalla questionnaires were administered. 
We enrolled 304 patients with a mean age of 68.12±10.83 years. The mean score of HKT was 15.33±2.79. 
CFA indicated that the construct being tested was unidimensional, and Cronbach’s alpha (α=0.65) showed 
that the instrument had an acceptable internal consistency. When evaluating concurrent validity, HKT 
was significantly correlated with the Batalla and Strelec scores. Thus, the Portuguese version of HKT 
(HKT-pt-PT) can be used either in research or in clinical practice. With this version, a potential standard 
exists to evaluate knowledge about hypertension, which could avoid the practice of using non-validated 
questionnaires in Portugal and allow the cross-sectional and longitudinal comparability of studies.
Keywords: Health Knowledge/attitudes/practice. Hypertension/prevention and control. Psychometrics. 
Surveys and questionnaires/standards. Portugal
INTRODUCTION
Control of hypertension is of central importance 
in cardiovascular disease prevention strategies (Mittal, 
Singh, 2010). However, despite all efforts, blood 
pressure (BP) control remains below expectations, 
with control rates ranging between 12% and 50% 
(Mittal, Singh, 2010; Kearney et al., 2005; Wolf-Maier 
et al., 2003; Erdine, Aran, 2004; Pereira et al., 2009). 
The Physa study reported that 42.2% of Portuguese 
adults are hypertensive, 74.9% are being treated with 
antihypertensives, and 42.6% have BP within the 
therapeutic objectives (Polonia et al., 2014).
Patients’ knowledge about hypertension was 
highlighted as one of the most important patient-related 
factors for poor blood pressure control (Atallah et al., 
2011). Knowledge on hypertension was associated with 
medication adherence and subsequently with BP control 
(Almas et al., 2012). Patients who have been educated 
about the importance of treatment become more involved 
with their therapy (Elliott, 2008; Powers, Jalowiec, 1987). 
The lack of knowledge of appropriate systolic BP was 
identified as a risk factor for poor blood pressure control 
(Atallah et al., 2011; Knight et al., 2001; Alexander et 
al., 2003). These patients are less likely to take their 
medication, adopt healthy lifestyle changes, or see their 
physician if their blood pressure is outside the ideal range 
(Atallah et al., 2011; Knight et al., 2001; Alexander et 
al., 2003).
While many studies have evaluated patient 
awareness of hypertension (Pereira et al., 2009; Polonia 
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et al., 2014; Joffres et al., 2013; Gee et al., 2012; Guessous 
et al., 2012; Macedo et al., 2007), critical elements of BP 
knowledge have not been adequately assessed. Developing 
instruments to assess knowledge is an important step to 
design effective intervention strategies for the control 
of BP. Several instruments have been used to evaluate 
patient knowledge about hypertension (Pineiro et al., 
1997; Batalla-Martínez, 1984; Strelec, Pierin, Mion 
Jr., 2003), but validated instruments reporting their 
internal consistency and reliability are scarce. The 
Hypertension Knowledge Test (HKT) (Han et al., 2011) 
is a questionnaire initially created to assess the knowledge 
about hypertension in Korean-American patients. The 
HKT is an easy-to-use questionnaire covering several 
aspects of hypertension, as its etiology, diagnosis, 
treatment and prevention. The HKT presents probably 
the most robust analysis of psychometric properties, 
demonstrating good internal consistency (α=0.70), and 
is a sensitive and reliable instrument (Han et al., 2011).
Although in Portugal some studies have evaluated 
the knowledge of hypertensive patients regarding their 
disease and the relationship between knowledge and 
BP control (Prior et al., 2001; Morgado et al., 2010), no 
validated instrument for this purpose exists. Thus, the 
objective of this study was to validate the European-
Portuguese adaptation of the Hypertension Knowledge 
Test questionnaire. Specifically, this study aimed to 
examine its factorial structure with a confirmatory analysis 
and to estimate its convergent and construct validities. 
METHOD
This was a cross-sectional study. Data were collected 
in 7 community pharmacies in the central region of 
Portugal and in the Hospital Infante D. Pedro in Aveiro. 
The study was approved by the Ethics Committee of 
the Faculty of Medicine of the University of Coimbra 
(Registration number CE_105.2013). 
Hypertension knowledge test
HKT was developed based on the National HBP 
Education Program of the National Heart, Lung, and 
Blood Institute (Check Your High Blood Pressure (IQ)), a 
literature review and community input. HKT is a 21-item 
questionnaire created to assess a patient’s knowledge 
about hypertension. HKT comprises the following two 
parts: 12 true-or-false questions and 9 multiple-choice 
questions. The level of knowledge is calculated by 
assigning one point to each correct answer, obtaining a 
total score ranging from 0 to 21.
Translation and cross-cultural adaptation of the 
HKT
A process of translation and back-translation 
according to international guidelines was performed 
(Guillemin, Bombardier, Beaton, 1993; Wild et al., 
2005). After obtaining the author’s permission, the 
original questionnaire was submitted to 3 bilingual 
translators who knew the goals and concepts of the study, 
who created 3 independent Portuguese translations. 
The three versions were compared in order to generate 
a consensus version. The reverse translation, from 
European-Portuguese to English, was carried out by 
another bilingual translator who was not involved in 
developing the initial version and who did not know 
the objectives and concepts of the study. This new 
English version was compared to the original version, 
and occasional discrepancies were corrected. Finally, 
a cross-culturally adapted version was obtained 
through a consensus meeting, attended by 2 experts in 
pharmacology and 1 expert in Portuguese language, who 
evaluated the versions’ semantic, idiomatic, cultural and 
conceptual equivalence.
A pilot test was performed in a Portuguese population 
(n=20) to ensure patient understanding and identify doubts 
and difficulties in the use of the questionnaire. The patients 
who participated in this face-validity phase were not 
further included in the study. After small adjustments 
based on changes proposed, we obtained the final 
European-Portuguese version of the HKT. Following the 
ISO-639 and ISO-3166, the European-Portuguese version 
of HKT was abbreviated as HKT-pt-PT. 
Batalla test
Originally, Batalla was developed to assess patient 
knowledge regarding hypertension. It consists of 
3 questions: “Is Hypertension a disease for life?”, 
“Hypertension can be controlled with diet and/or 
medication?”, and “Name 2 or more organs affected 
by increased blood pressure”. The patient is classified 
as having good knowledge by correctly answering all 
questions (Batalla-Martínez, 1984; Pineiro et al., 1997).
Strelec test
Strelec is an instrument developed to assess 
patients’ awareness of hypertension and its treatment 
(Strelec, Pierin, Mion Jr., 2003). It consists of 10 true-
or-false questions. One point is attributed to each correct 
answer, and the final score is calculated by summing the 
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points obtained. Higher scores mean a greater level of 
consciousness regarding hypertension.
Medida de adesão aos tratamentos
The Medida de Adesão aos Tratamentos (MAT) 
(Delgado, Lima, 2001) is a questionnaire developed to 
assess patients’ adherence to medication. It consists of 
7 items each rated on a six-point Likert scale, ranging 
from 1 (“always”) to 6 (“never”). The level of adherence 
is obtained by adding the values of each item and then 
dividing by the total number of items. Higher scores mean 
a greater level of adherence. The classification of patients 
as adherent or non-adherent is made according scores near 
the median values.
Data collection
Data were collected between March and August 
2014, and the HKT-pt-PT was applied to a sample of at 
least 300 patients. Inclusion criteria were adult patients 
taking at least one antihypertensive drug. All patients 
who met the inclusion criteria and were being treated by 
the participating pharmacies and hospital in the study 
were invited to participate. The interview was conducted 
by a trained pharmacist in a private office, where data on 
personal and family history were collected and the HKT-
pt-PT, MAT, Strelec, and the Batalla instruments were 
administered. Due to the use of this interview method, 
all participants’ answers were coded, so there were no 
missing values.
Statistical analysis
To examine the factorial structure of the HKT-pt-
PT, a confirmatory factor analysis (CFA) using MPlus 
6 was performed (Muthén, 1998/2010). The model was 
estimated using the maximum likelihood (MLMV) 
method, which provides robust standard errors and robust 
chi-square in case of deviation from normality, adjusting 
for mean and variance (Muthén, 1998/2010). 
According to Kline (2008), samples above 300 
participants are considered large and therefore adequate 
to use analysis such as the CFA. To evaluate overall model 
fit, we used the chi-square goodness-of-fit statistic, where 
non-significant values indicate good fit of the model to 
the data. In addition, we followed the recommendation 
that other fit indices be used to ascertain model fit (Kline, 
2008), namely, the comparative fit index (CFI), the 
standardized root-mean-square residual (SRMR) and 
the root mean square error of approximation (RMSEA). 
Model fit is considered adequate or good when the CFI 
is above 0.90 or 0.95, the SRMR is below 0.10, and the 
RMSEA is below 0.10 or 0.08 (Kline, 2008). The report of 
the combination of these fit indices has been recommended 
for a better analysis on the model fit (Hu, Bentler, 1999).
Whenever a model did not fit the data well, the 
model was inspected for respecification, and alternative 
models were also tested. The development of competing 
models was based on theoretical considerations and 
analysis of the data. Finally, the internal consistency of 
the HKT-pt-PT was estimated using Cronbach’s alpha.
RESULTS
Study participants
There were 304 patients enrolled in the study. The 
mean age was 68.12±10.83 years, and 162 (53.3%) were 
female. The average time since hypertension diagnosis was 
11.13±8.65 years, with maximum disease duration of 50 
years. In this population, 171 (56.3%) had dyslipidemia, 
91 (29.9%) diabetes, 89 (27.6%) heart disease, and 28 
(9.2%) had already had a stroke. Of the 162 women 
enrolled, 13 (4.3%) had history of hypertension during 
pregnancy. The adherence mean score obtained for MAT 
was 5.78±0.27.
The mean score obtained for HKT-pt-PT was 
15.33±2.79. Table I summarizes the proportion of correct 
responses to each item. Table II describes the frequencies 
of answers to the multiple choice questions.
Confirmatory factor analysis
The first CFA model included all 21 items of the 
HKT loaded into one global factor, Overall Knowledge of 
Hypertension. The model revealed a poor fit to the data, 
with, with χ2 (189) = 226.68, p=0.03; CFI = 0.78; RMSEA 
= 0.03 [90% confidence interval: 0.01; 0.4]; and SRMR = 
0.05. The analysis of modification indices and the evaluation 
of each item phrasing suggested that the introduction of 
error correlations (between items 8 and 11, items 13 and 
15 and items 16 and 19) would improve model fit and 
were included in the model. The final model presented an 
adequate fit, with χ2 (182) = 200.12, p=0.23; CFI = 0.92; 
RMSEA = 0.02 [90% confidence interval: 0.00; 0.03]; and 
SRMR = 0.05, indicating that the construct being tested, 
knowledge on hypertension, was unidimensional.
Internal consistency and validity
Cronbach’s alpha for all items was 0.65, and the 
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removal of any item would not have affected alpha 
significantly. The values of the alphas if an item was 
deleted and the item total correlations are reported in 
Table III. 
Convergent validity was estimated by correlating the 
final score of the HKT-pt-PT with other measures assessing 
the same construct. The HKT-pt-PT was moderately and 
significantly correlated with the Batalla (0.32, p<0.001) 
and Strelec scores (0.31, p<0.001), confirming that both 
instruments assess correlated constructs. 
Construct validity was estimated by examining 
differences in adherence based on knowledge of 
hypertension, as assessed by the HKT-pt-PT score. Based 
on the median (15), groups were formed: scores below the 
mean were considered lower knowledge, and scores above 
the mean were considered high knowledge. Participants 
with lower knowledge (<15) had a mean MAT score of 
5.74±0.33, and those with higher knowledge (≥15) had a 
mean score of 5.81±0.22 (t = -2.29, p=0.04)
DISCUSSION
Our study aimed to examine the factorial structure 
and validity of the European-Portuguese version of the 
HKT (HKT-pt-PT). To our knowledge, this is the first study 
using confirmatory analysis procedures to examine the 
TABLE I - Proportion of correct answers on the Hypertension Knowledge Test (n=304)
Item Response format
Correct answer
n %
Q1. Se a sua mãe ou pai tiverem hipertensão o seu risco de tornar-se hipertenso 
é maior
T/F 225 74
Q2. Jovens adultos não têm hipertensão T/F 279 91.8
Q3. A hipertensão tem sempre sintomas T/F 170 55.9
Q4. A hipertensão não põe a vida em risco T/F 298 98
Q5. A pressão arterial é alta quando é igual ou superior a 140/90 mmHg T/F 257 84.5
Q6. Se tiver peso a mais tem um risco 2 a 6 vezes maior de desenvolver 
hipertensão
T/F 298 98
Q7. Exercício físico regular pode ajudar a reduzir a pressão arterial T/F 258 84.9
Q8. Os portugueses consomem 2 a 3 vezes mais sal ou sódio do que necessitam T/F 286 94.1
Q9. Beber bebidas alcoólicas reduz a pressão arterial T/F 205 67.4
Q10. A hipertensão é um problema apenas dos homens T/F 303 99.7
Q11. Hipertensão na gravidez é um problema temporário e não necessita de 
acompanhamento após o parto
T/F 219 72
Q12. A pressão arterial diminui com o tempo frio T/F 121 39.8
Q13. A hipertensão prejudica o seu organismo ao longo do tempo por: MC 102 33.6
Q14. Porque é que a Hipertensão é chamada um “assassino silencioso”? MC 292 96.1
Q15. Uma pessoa é diagnosticada com hipertensão se tiver: MC 99 32.6
Q16. Uma boa pressão arterial é: MC 297 97.7
Q17. Qual das seguintes afirmações é verdadeira sobre os medicamentos para 
a hipertensão:
MC 95 31.3
Q18. Qual das seguintes afirmações é falsa sobre os medicamentos para a 
hipertensão:
MC 145 47.7
Q19. Todos os seguintes problemas de saúde podem ser provocados pela 
hipertensão, exceto:
MC 216 71.1
Q20. Todas as seguintes afirmações são alterações que pode fazer na sua dieta 
para reduzir a sua pressão arterial, exceto:
MC 392 96.1
Q21. Todas as seguintes alterações do estilo de vida podem ajudar a baixar a 
sua pressão arterial, exceto:
MC 204 67.1
Abbreviation: MC=multiple choice; T/F=true or false.
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TABLE II - Frequencies of answers of multiple choices questions
n %
Q13. A hipertensão prejudica o seu organismo ao longo do tempo por:
     Fazer com que tenha diabetes 33 10.9
     Fazer com que ganhe peso 6 2
     Danificar os seus vasos sanguíneos 102 33.6
     Deixá-lo nervoso 114 37.5
Q14. Porque é que a Hipertensão é chamada um “assassino silencioso”?
      O risco de morrer de hipertensão é baixo 0 0
     Quando não há dor nem se sente doente é porque se está bem 7 2.3
     Pode não ter sintomas e pode por a vida em risco 293 96.4
Q15. Uma pessoa é diagnosticada com hipertensão se tiver:
     Muitas dores de cabeça que persistem há mais de 6 meses 72 23.7
     Um familiar com hipertensão 4 1.3
     Stress e pressão constantes 92 30.3
     Pressão arterial elevada em 3 ocasiões diferentes 99 32.6
Q16. Uma boa pressão arterial é:
     Menos de 90/50 mmHg 0 0
     Menos que 140/90 mmHg 297 97.7
     145/110 mmHg 5 1.6
     180/100 mmHg 0 0
Q17. Qual das seguintes afirmações é verdadeira sobre os medicamentos para a hipertensão:
     Há muitos tipos de medicamentos para a Hipertensão 95 31.1
     Deve ser tomada uma medicação extra quando a pressão arterial está alta 147 48.4
     Os medicamentos não devem ser tomados se se beber álcool 42 13.8
     Todos os medicamentos causam impotência sexual 0 0
Q18. Qual das seguintes afirmações é falsa sobre os medicamentos para a hipertensão:
     Tomar os medicamentos para a Hipertensão durante muito tempo pode prejudicar o seu organismo 145 47.7
     A partir do momento em que começa a tomar medicação tem de continuar a tomá-la a vida toda 113 37.2
     Mesmo que se sinta bem tem de tomar a medicação como o prescrito 20 6.6
     Quando sente que a dose dos medicamentos deve ser alterada, deve falar primeiro com o seu médico 0 0
Q19. Todos os seguintes problemas de saúde podem ser provocados pela hipertensão, exceto:
     Ataque cardíaco 7 2.3
     Artrite 215 70.7
     AVC 22 7.2
     Insuficiência Renal 43 14.1
Q20. Todas as seguintes afirmações são alterações que pode fazer na sua dieta para reduzir a sua 
pressão arterial, exceto:
     Comer frango assado em vez de frito 6 2
     Parar de comer batatas fritas 1 0.3
     Evitar adicionar sal de mesa à comida 3 1
     Comer fast-food ou fritos 291 95.7
Q21. Todas as seguintes alterações do estilo de vida podem ajudar a baixar a sua pressão arterial, exceto:
     Levantar 50 kg 210 69.1
     Andar vigorosamente 30 minutos 3 vezes por semana 21 6.9
     Beber menos do que 2 bebidas alcoólicas por dia 48 15.8
     Parar de fumar 7 2.3
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factor structure of the HKT, confirming the measurement 
model of the instrument and the unidimensional theoretical 
structure of the instrument (Kline, 2008). Our findings 
indicate that all the items contribute to the assessment of 
knowledge on hypertension.
T h e  o r i g i n a l  v a l i d a t i o n  w a s  p e r f o r m e d 
by administering the questionnaire to two distinct 
samples, in study 1, to middle-aged hypertensives 
(mean age=51.9±5.7 years); and in study 2, to elderly 
hypertensives (mean age=70.9±5.5 years) (Han et al., 
2011). The results were presented separately for each 
study and for the total sample. If we compared our 
Cronbach’s alpha (α=0.65) to that obtained in the total 
sample of the original validation (α=0.70), ours was 
lower. However, if we made the comparison with the 
alpha obtained in study 2 (α=0.62), which had a mean 
population age more similar to ours, we obtained a 
higher alpha. Although we obtained a Cronbach’s alpha 
of <0.70, it was high enough to consider that HKT-pt-PT 
presents an acceptable internal consistency. One possible 
explanation for a Cronbach’s alpha slightly below the 
recommended value may be the existence of some 
uncorrelated items. In the Portuguese version, values of 
item total correlation (ITC) range between -0.1 and 0.40, 
and 6 items (Q2, Q3, Q4, Q10, Q14 and Q20) did not meet 
the cutoff of 0.15 (Nunnally, Bernstein, 1994). In study 2 
of the original validation, ITC ranged between 0.11 and 
0.32, and two items, Q3 and Q6, did not meet that cutoff. 
The fact that these items do not contribute much to the 
final score may be due largely to the high percentage of 
correct answers that they present. This can be explained 
by the characteristics of the population surveyed since 
TABLE III - Internal consistency reliability of the Hypertension Knowledge Test
Item
Item-total 
correlation 
coefficient
Cronbach alfa if 
item deleted
Q1. Se a sua mãe ou pai tiverem hipertensão o seu risco de tornar-se hipertenso é maior 0.30 0,63
Q2. Jovens adultos não têm hipertensão 0.03 0.66
Q3. A hipertensão tem sempre sintomas 0.03 0.67
Q4. A hipertensão não põe a vida em risco 0.13 0.65
Q5. A pressão arterial é alta quando é igual ou superior a 140/90mmHg 0.24 0.64
Q6. Se tiver peso a mais tem um risco 2 a 6 vezes maior de desenvolver hipertensão 0.20 0.65
Q7. Exercício físico regular pode ajudar a reduzir a pressão arterial 0.25 0.64
Q8. Os portugueses consomem 2 a 3 vezes mais sal ou sódio do que necessitam 0.30 0.64
Q9. Beber bebidas alcoólicas reduz a pressão arterial 0.33 0.63
Q10. A hipertensão é um problema apenas dos homens -0.1 0.63
Q11. Hipertensão na gravidez é um problema temporário e não necessita de 
acompanhamento após o parto
0.34 0.65
Q12. A pressão arterial diminui com o tempo frio 0.18 0.62
Q13. A hipertensão prejudica o seu organismo ao longo do tempo por: 0.39 0.65
Q14. Porque é que a Hipertensão é chamada um “assassino silencioso”? 0.10 0.63
Q15. Uma pessoa é diagnosticada com hipertensão se tiver: 0.31 0.65
Q16. Uma boa pressão arterial é: 0.23 0.64
Q17. Qual das seguintes afirmações é verdadeira sobre os medicamentos para a 
hipertensão:
0.28 0.63
Q18. Qual das seguintes afirmações é falsa sobre os medicamentos para a hipertensão: 0.33 0.64
Q19. Todos os seguintes problemas de saúde podem ser provocados pela hipertensão, 
exceto:
0.26 0.65
Q20. Todas as seguintes afirmações são alterações que pode fazer na sua dieta para 
reduzir a sua pressão arterial, exceto:
0.05 0.62
Q21. Todas as seguintes alterações do estilo de vida podem ajudar a baixar a sua pressão 
arterial, exceto:
0.40 0.63
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we applied the instrument to hypertensive patients under 
treatment, with good levels of adherence. If removal of 
any item would not affect alpha significantly, the removal 
of this item could cause this questionnaire to cease being 
valid for application in other contexts, particularly in a 
less informed population.
Analyzing the answers obtained in the multiple-
choice questions, we saw that Q13, Q15, Q17 and Q18 
were the questions that caused the most doubt in the 
patients, as less than 50% of patients provided correct 
answers. In Q17 (“Which of the following statements is 
true about HBP medications?”), approximately 48% of 
patients responded that “An extra medication should be 
taken when blood pressure is high.” One possible reason for 
this result is that the question could be misinterpreted: the 
patients confused taking an extra dose of medication with 
taking another medication. Thus, in future applications 
of HKT-pt-PT, it may be useful to consider an alternative 
wording for this question, for example, by replacing the 
expression “medicação extra” with “medicação adicional”.
The difficulties in accurately answering items 13, 
15 and 18 may be explained by the low level of health 
literacy that the Portuguese population presents (Salgado 
et al., 2013). These results are similar to those obtained by 
Williams et al. (1998), where patients with poor literacy 
skills were less likely to answer knowledge questions 
correctly. Health literacy is independently correlated 
with disease knowledge (Gazmararian et al., 2003), and 
there are several studies showing that patients with lower 
literacy levels have lower levels of knowledge about 
their disease (Williams et al., 1998; American Medical 
Association, 1999; Mosher et al., 2012). The Portuguese 
population’s health literacy is low. Salgado et al. (2013), 
measuring health literacy with the Newest Vital Sign, 
reported that 95% of the Portuguese respondents scored 
in the three lowest possible scores, indicating a notable 
floor effect.
Health literacy is inversely associated with age 
(Williams et al., 1998; Paasche-Orlow et al., 2005; 
Kobayashi et al., 2015); thus, patients with marginal 
and inadequate literacy are older than patients with 
adequate literacy, meaning that older patients should 
have worse knowledge about their disease. However, 
in the HKT original validation study, Han et al. (2011) 
showed that knowledge about hypertension increases 
with age and with time of disease. Similar results were 
obtained by Hyre et al. (2007), where patients diagnosed 
with hypertension for ten or more years were more 
likely to have a better understanding of the importance 
of medication-taking behaviors and their effects on 
long-term health. These findings suggest that personal 
experience with hypertension and cardiovascular disease, 
rather than basic knowledge, may lead to improved 
adherence behavior. Thus, when developing strategies to 
improve blood pressure control, particular characteristics 
of knowledge about hypertension must be taken into 
account, requiring the utilization of specific validated 
instruments.
The final score of the HKT-pt-PT was correlated 
with other measures assessing similar constructs, Batalla 
and Strelec. HKT-pt-PT was moderately and significantly 
correlated with both instruments, showing that the 
construct is correlated but not exactly the same. In fact, 
HKT allows us to evaluate knowledge about hypertension, 
not only that related to the symptoms and diagnosis of 
the disease but also that related to the ways of preventing 
and controlling high blood pressure, antihypertensive 
medications, and the harmful effects of hypertension over 
time. These multifaceted characteristics are an added 
value that will enable us to obtain more complete and 
specific information about patients’ knowledge about this 
condition.
LIMITATIONS OF THE STUDY
A potential limitation of our study was the 
questionnaire application mode used. We used the 
interviewer-administration method, which may lead to 
some bias (Okamoto et al., 2002; Puhan et al., 2011). 
However, we considered the interview the best method to 
allow the inclusion of patients with very low literacy since 
we want the validated instrument to be applicable in every 
type of population, regardless of their degree of literacy.
CONCLUSION
We obtained a European-Portuguese version of the 
HKT (HKT-pt-PT) with acceptable internal consistency, 
discriminatory capacity, and predictive power regarding 
adherence, which can be used either in research or in 
clinical practice. Now a potential standard exists that could 
avoid the practice of using non-validated questionnaires 
in Portugal. This will allow the cross-sectional and 
longitudinal comparability of studies. 
With this questionnaire, not only clinicians and 
researchers but also health policy decision makers can 
assess the gaps in patients’ knowledge about hypertension 
and consequently develop educational activities. 
Future research is warranted to assess whether 
knowledge evaluated by the HKT-pt-PT can be associated 
with process variables, such as adherence or outcome 
variables, including blood pressure control.
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